Cancer-Focused Biopharma Co. Snags $100M From Investors
A host of private equity and investment firms poured $100 million into Massachusetts-based Constellation Pharmaceuticals Inc., the biopharmaceutical company announced Monday, as it looks to advance several candidates in its cancer-focused...To view the full article, register now.
Already a subscriber? Click here to view full article